Annika Wittich profile page

Annika is a scientific researcher at the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Discovery Research ScreeningPort.

Her prime focus is the application of human-induced pluripotent stem cells and their differentiation into disease-affected cell types for drug discovery. She implements automation-compatible high-throughput screening assays using these human cellular models to identify known drugs for alternative targets and indications across different contexts of rare neurological diseases.

She received a master's in molecular life sciences from the University of Hamburg in May 2022. In April 2026, she successfully defended her doctoral thesis with the title: "Drug discovery for rare neurological disorders using human cellular models".